A trial has been launched in the UK to test whether ibuprofen can help with breathing difficulties in COVID-19 hospital patients.
Scientists hope a modified form of the anti-inflammatory drug and painkiller will help to relieve respiratory problems in people who have more serious coronavirus symptoms but do not need intensive care unit treatment.
Half the patients participating in the trial will be administered with the drug in addition to their usual care, while the other half will receive standard care to analyse the effectiveness of the treatment.
Read full story
Source: The Independent, 3 June 2020